Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:54-58

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natale, A.
Right arrow Articles by Sra, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natale, A.
Right arrow Articles by Sra, J. S.

(Circulation. 1995;92:54-58.)
© 1995 American Heart Association, Inc.


Articles

Provocation of Hypotension During Head-Up Tilt Testing in Subjects With No History of Syncope or Presyncope

Andrea Natale, MD; Masood Akhtar, MD; Mohammad Jazayeri, MD; Anwer Dhala, MD; Zalmen Blanck, MD; Sanjay Deshpande, MD; Anita Krebs, RN; Jasbir S. Sra, MD

From the Electrophysiology Laboratory, Milwaukee Heart Institute of Sinai Samaritan Medical Center and St Luke's Hospital, University of Wisconsin-Milwaukee Clinical Campus, Milwaukee, Wis.

Correspondence to Jasbir S. Sra, MD, 2901 W KK River Pkwy, #470, Milwaukee, WI 53215-3660.

Background Head-up tilt test is increasingly being used to evaluate patients with syncope. This study was designed to evaluate the specificity of head-up tilt testing using different tilt angles and isoproterenol infusion doses in normal volunteers with no prior history of syncope or presyncope.

Methods and Results One hundred fifty volunteers were randomized to two groups of 75 each. In group 1, subjects were further randomized to have head-up tilt testing at a 60, 70, or 80 degree angle at baseline followed by repeat tilt testing during a low-dose isoproterenol infusion that increased the heart rate by an average of 20%. In group 2, after having a baseline head-up tilt test at a 70 degree angle for a maximum of 20 minutes, subjects were randomized to have a repeat tilt table testing at a 70 degree angle during a low-dose, 3 µg/min, or 5 µg/min isoproterenol infusion. In group 1, syncope or presyncope along with hypotension developed in 2 subjects during the baseline test at 60 and 70 degrees of tilt and in 5 subjects during tilting at 80 degrees. The addition of low-dose isoproterenol reduced the specificity minimally from 92% to 88% at both 60 and 70 degrees of tilt but substantially to 60% at an 80 degree angle. However, 6 of the 10 subjects with a positive test at an 80 degree angle had an abnormal response after 10 minutes of tilt testing. In group 2, using various isoproterenol doses with tilt table testing at a 70 degree angle, low-dose (mean infusion dose, 1.5±0.45 µg/min), 3 µg/min, and 5 µg/min isoproterenol infusions elicited an abnormal response in 1 (4%), 5 (20%), and 14 (56%) of the subjects, respectively. Using multiple logistic regression analysis, head-up tilt testing at an 80 degree angle (P=.01) or during 3 µg/min (P=.02) and 5 µg/min isoproterenol infusion rates (P<.001) was the most significant predictor of an abnormal response.

Conclusions Head-up tilt testing at a 60 or 70 degree angle with or without low-dose isoproterenol infusion provides an adequate specificity. Caution is needed, however, in interpreting the results if the head-up tilt test at 80 degrees is extended beyond 10 minutes or if high doses of isoproterenol are used.


Key Words: hypotension • tilt test • syncope




This article has been cited by other articles:


Home page
PediatricsHome page
A. P. Vlahos, M. Tzoufi, C. S. Katsouras, T. Barka, I. Sionti, L. K. Michalis, A. Siamopoulou, and T. M. Kolettis
Provocation of Neurocardiogenic Syncope During Head-up Tilt Testing in Children: Comparison Between Isoproterenol and Nitroglycerin
Pediatrics, February 1, 2007; 119(2): e419 - e425.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Schroeder, A. L. Birkenfeld, A. F. Mayer, J. Tank, A. Diedrich, F. C. Luft, and J. Jordan
Norepinephrine Transporter Inhibition Prevents Tilt-Induced Pre-Syncope
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. P. Grubb
Neurocardiogenic Syncope
N. Engl. J. Med., March 10, 2005; 352(10): 1004 - 1010.
[Full Text] [PDF]


Home page
EuropaceHome page
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology
Europace, January 1, 2004; 6(6): 467 - 537.
[Full Text] [PDF]


Home page
JAMAHome page
W. N. Kapoor
Is There an Effective Treatment for Neurally Mediated Syncope?
JAMA, May 7, 2003; 289(17): 2272 - 2275.
[Full Text] [PDF]


Home page
CirculationHome page
W. N. Kapoor
Current Evaluation and Management of Syncope
Circulation, September 24, 2002; 106(13): 1606 - 1609.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Raviele
Tilt-induced asystole: a useful prognostic marker or clinically unrelevant finding?
Eur. Heart J., March 2, 2002; 23(6): 433 - 437.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al.
Guidelines on management (diagnosis and treatment) of syncope
Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306.
[Abstract] [PDF]


Home page
Eur Heart JHome page
L.A Graham, J.C Gray, and R.A Kenny
Comparison of provocative tests for unexplained syncope: isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope
Eur. Heart J., March 2, 2001; 22(6): 497 - 503.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
A. H. Madrid, J. Ortega, J. G. Rebollo, J. G. Manzano, J. G. Segovia, A. Sanchez, G. Pena, and C. Moro
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. S. Sra
Can we assess the efficacy of therapy in neurocardiogenic syncope?
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 560 - 561.
[Full Text] [PDF]


Home page
CMAJHome page
M. Lamarre-Cliche and J. Cusson
The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance
Can. Med. Assoc. J., February 1, 2001; 164(3): 372 - 376.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Sheldon and S. Rose
Components of clinical trials for vasovagal syncope
Europace, January 1, 2001; 3(3): 233 - 240.
[Abstract] [PDF]


Home page
NEJMHome page
W. N. Kapoor
Syncope
N. Engl. J. Med., December 21, 2000; 343(25): 1856 - 1862.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. M. Fenton, S. C. Hammill, R. F. Rea, P. A. Low, and W.-K. Shen
Vasovagal Syncope
Ann Intern Med, November 7, 2000; 133(9): 714 - 725.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M E V Petersen, T R Williams, C Gordon, R Chamberlain-Webber, and R Sutton
The normal response to prolonged passive head up tilt testing
Heart, November 1, 2000; 84(5): 509 - 514.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
A. P. Fitzpatrick and A. Zaidi
Tilt methodology in reflex syncope: emerging evidence
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 179 - 180.
[Full Text] [PDF]


Home page
HeartHome page
R A Kenny, D O'Shea, and S W Parry
The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders
Heart, May 1, 2000; 83(5): 564 - 569.
[Full Text]


Home page
HeartHome page
A Zaidi, D Benitez, P A Gaydecki, A Vohra, and A P Fitzpatrick
Haemodynamic effects of increasing angle of head up tilt
Heart, February 1, 2000; 83(2): 181 - 184.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
F. M. Leonelli, K. Wang, J. M. Evans, A. R. Patwardhan, M. G. Ziegler, A. Natale, C. S. Kim, K. Rajikovich, and C. F. Knapp
False positive head-up tilt:: Hemodynamic and neurohumoral profile
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 188 - 193.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. Kosinski, B.P. Grubb, B.J. Karas, and S. Frederick
Exercise-induced neurocardiogenic syncope: Clinical data, pathophysiological aspects, and potential role of tilt table testing
Europace, January 1, 2000; 2(1): 77 - 82.
[Abstract] [PDF]


Home page
CirculationHome page
S. Mittal, K. M. Stein, S. M. Markowitz, D. J. Slotwiner, S. Rohatgi, and B. B. Lerman
Induction of Neurally Mediated Syncope With Adenosine
Circulation, March 16, 1999; 99(10): 1318 - 1324.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W.-K. Shen, A. Jahangir, D. Beinborn, C. M. Lohse, D. O. Hodge, R. F. Rea, and S. C. Hammill
Utility of a single-stage isoproterenol tilt table test in adults: A randomized comparison with passive head-up tilt
J. Am. Coll. Cardiol., March 15, 1999; 33(4): 985 - 990.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W. SMITH
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine
Heart, January 1, 1998; 79(1): 105 - 105.
[Full Text]


Home page
CirculationHome page
Z. Mallat, E. Vicaut, A. Sangare, J. Verschueren, G. Fontaine, and R. Frank
Prediction of Head-Up Tilt Test Result by Analysis of Early Heart Rate Variations
Circulation, July 15, 1997; 96(2): 581 - 584.
[Abstract] [Full Text]